1. Home
  2. SILO vs JTAI Comparison

SILO vs JTAI Comparison

Compare SILO & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • JTAI
  • Stock Information
  • Founded
  • SILO 2010
  • JTAI 2018
  • Country
  • SILO United States
  • JTAI United States
  • Employees
  • SILO N/A
  • JTAI N/A
  • Industry
  • SILO Apparel
  • JTAI Blank Checks
  • Sector
  • SILO Consumer Discretionary
  • JTAI Finance
  • Exchange
  • SILO Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • SILO 8.8M
  • JTAI 7.1M
  • IPO Year
  • SILO N/A
  • JTAI N/A
  • Fundamental
  • Price
  • SILO $1.65
  • JTAI $2.52
  • Analyst Decision
  • SILO
  • JTAI
  • Analyst Count
  • SILO 0
  • JTAI 0
  • Target Price
  • SILO N/A
  • JTAI N/A
  • AVG Volume (30 Days)
  • SILO 805.4K
  • JTAI 160.0K
  • Earning Date
  • SILO 02-18-2025
  • JTAI 03-31-2025
  • Dividend Yield
  • SILO N/A
  • JTAI N/A
  • EPS Growth
  • SILO N/A
  • JTAI N/A
  • EPS
  • SILO N/A
  • JTAI N/A
  • Revenue
  • SILO $72,102.00
  • JTAI $15,028,926.00
  • Revenue This Year
  • SILO $1.86
  • JTAI $21.49
  • Revenue Next Year
  • SILO N/A
  • JTAI $10.05
  • P/E Ratio
  • SILO N/A
  • JTAI N/A
  • Revenue Growth
  • SILO N/A
  • JTAI 46.66
  • 52 Week Low
  • SILO $0.77
  • JTAI $2.30
  • 52 Week High
  • SILO $4.50
  • JTAI $315.00
  • Technical
  • Relative Strength Index (RSI)
  • SILO 52.57
  • JTAI 33.13
  • Support Level
  • SILO $1.56
  • JTAI $2.30
  • Resistance Level
  • SILO $1.89
  • JTAI $2.60
  • Average True Range (ATR)
  • SILO 0.19
  • JTAI 0.28
  • MACD
  • SILO -0.05
  • JTAI 0.01
  • Stochastic Oscillator
  • SILO 27.12
  • JTAI 15.15

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: